Nirma Limited acquires majority stake in Glenmark Life Sciences in strategic expansion into pharmaceuticals
In a significant move within the pharmaceutical and life sciences sector, Nirma Limited, a conglomerate known for its ventures in consumer products, chemicals, and pharmaceuticals, has announced the acquisition of a 75% stake in Glenmark Life Sciences from Glenmark Pharmaceuticals. This acquisition, involving 91,895,379 equity shares, marks a pivotal moment for Nirma Limited as it […]